Detalhe da pesquisa
1.
Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms.
Breast Cancer Res
; 25(1): 123, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37817263
2.
Proteogenomic Workflow Reveals Molecular Phenotypes Related to Breast Cancer Mammographic Appearance.
J Proteome Res
; 20(5): 2983-3001, 2021 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33855848
3.
The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies.
Proteomics
; 16(10): 1474-85, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27030549
4.
Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera.
J Proteome Res
; 15(4): 1230-42, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26958999
5.
Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response.
Mol Cell Proteomics
; 13(7): 1814-27, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24742827
6.
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling.
Sci Rep
; 14(1): 6873, 2024 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38519482
7.
Quantitative proteomic analysis of microdissected breast cancer tissues: comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches.
J Proteome Res
; 12(10): 4627-41, 2013 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23957277
8.
Proteogenomics decodes the evolution of human ipsilateral breast cancer.
Commun Biol
; 6(1): 139, 2023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36732562
9.
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long-term follow-up of the SweBCG91RT randomized trial.
Mol Oncol
; 17(10): 2029-2040, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36975842
10.
A somatic mutation in moesin drives progression into acute myeloid leukemia.
Sci Adv
; 8(16): eabm9987, 2022 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35442741
11.
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics.
Mol Metab
; 64: 101561, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944897
12.
Regulatory Interplay between miR-181a-5p and Estrogen Receptor Signaling Cascade in Breast Cancer.
Cancers (Basel)
; 13(3)2021 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33535487
13.
Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer.
Cancers (Basel)
; 11(12)2019 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31888209
14.
Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer.
Sci Rep
; 7(1): 2099, 2017 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28522855
15.
Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer.
Drug Discov Today
; 21(7): 1181-8, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27233379
16.
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer.
Oncotarget
; 7(3): 3098-110, 2016 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26657294
17.
4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.
Mol Oncol
; 10(1): 24-39, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26285647
18.
Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients.
Sci Rep
; 6: 32027, 2016 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27558661
19.
Antibody-based capture of target peptides in multiple reaction monitoring experiments.
Methods Mol Biol
; 1293: 123-35, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26040685
20.
Global proteomic characterization of microdissected estrogen receptor positive breast tumors.
Data Brief
; 5: 399-402, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26958599